KD

Active Director Director DIN 09543875
DIN 09543875 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Kapil Dev

Data last updated:

Kapil Dev is a Director at Supervet Health Sciences Private Limited (since 2022). The company operates in Healthcare. Supervet Health Sciences Private Limited reported revenue of ₹44.8 Lakh (FY 2025).

DIN 09543875
Primary Designation Director
Industry Healthcare
First Appointment 23 Mar 2022
Oldest Company Age 5 yrs
Largest company Supervet Health Sciences Private Limited · ₹44.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Mar 20222021₹44.8 Lakh (FY 2025)Active

Board colleagues of Kapil Dev

NameDINCompanyDesignation
Shashikant Sai09211590Supervet Health Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Supervet Health Sciences Private Limited
Premium access

Shareholding and investment profile for Kapil Dev

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapil Dev

Kapil Dev currently holds 1 directorship: Supervet Health Sciences Private Limited (Director, since 23 Mar 2022, revenue ₹44.8 Lakh (FY 2025)).

Kapil Dev was first appointed on 23 Mar 2022 as Director at Supervet Health Sciences Private Limited.

The current boards of Kapil Dev's companies include Shashikant Sai (Supervet Health Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available